Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.2 USD | +4.33% | +3.19% | +1.63% |
May. 16 | Morgan Stanley Adjusts Ascendis Pharma Price Target to $140 From $116, Maintains Equal Weight Rating | MT |
May. 14 | US Equity Markets Close Higher Tuesday as Producer Prices Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.63% | 7.04B | |
+9.52% | 114B | |
+13.16% | 107B | |
-6.36% | 22.22B | |
-1.60% | 21.28B | |
-4.50% | 18.8B | |
-5.88% | 17.51B | |
-39.36% | 17.17B | |
+6.35% | 14.14B | |
+34.50% | 12.2B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- TD Bank Announcing "Significant Expansion" of Its Global Financial Institutions Group